Your browser doesn't support javascript.
loading
Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models.
Golan, Talia; Stossel, Chani; Atias, Dikla; Buzhor, Ella; Halperin, Sharon; Cohen, Keren; Raitses-Gurevich, Maria; Glick, Yulia; Raskin, Stephen; Yehuda, Daniel; Feldman, Anna; Schvimer, Michael; Friedman, Eitan; Karni, Rotem; Wilson, Julie M; Denroche, Robert E; Lungu, Ilinca; Bartlett, John M S; Mbabaali, Faridah; Gallinger, Steven; Berger, Raanan.
Afiliación
  • Golan T; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Stossel C; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Atias D; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Buzhor E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Halperin S; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Cohen K; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Raitses-Gurevich M; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Glick Y; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Raskin S; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Yehuda D; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Feldman A; Radiology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Schvimer M; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Friedman E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Karni R; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Wilson JM; Pathology Department, Sheba Medical Center, Tel Hashomer, Israel.
  • Denroche RE; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Lungu I; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel.
  • Bartlett JMS; Department of Biochemistry and Molecular Biology, IMRIC, Hebrew University - Hadassah Medical School, Jerusalem, Israel.
  • Mbabaali F; Ontario Institute for Cancer Research, Toronto, Canada.
  • Gallinger S; Ontario Institute for Cancer Research, Toronto, Canada.
  • Berger R; Ontario Institute for Cancer Research, Toronto, Canada.
Int J Cancer ; 143(1): 179-183, 2018 07 01.
Article en En | MEDLINE | ID: mdl-29396858
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Compuestos de Platino / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Compuestos de Platino / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article